Denna sida på svenska This page in English

Anna Sandström Gerdtsson

The advent of immunotherapy has resulted in significant survival benefits in cancer care. The immune response is however heterogeneous across tumors and individuals, rendering existing therapeutics non-effective for many patients. My research focuses on identification of biomarker signatures for patient stratification and new treatment strategies through comprehensive characterization of the tumor immune microenvironment.

Anna Sandström Gerdtsson


Phone: +46-46-222-9678


Department of Immunotechnology

Lund University

Medicon Village; Bldg 406

223 81 Lund, Sweden